BETA

Awaiting Parliament 1st reading / single reading / budget 1st stage



2014/2133(DEC) 2013 discharge: IMI Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines
RoleCommitteeRapporteurShadows
Lead CONT CZARNECKI Ryszard (ECR) MARINESCU Marian-Jean (EPP), BALČYTIS Zigmantas (S&D), DLABAJOVÁ Martina (ALDE), ŠOLTES Igor (Verts/ALE), VALLI Marco (EFD)
Opinion ENVI
Opinion ITRE
Lead committee dossier: CONT/8/01601

Activites

  • 2015/04/29 Vote in plenary scheduled
  • 2015/04/28 Debate in plenary scheduled
  • 2015/03/31 Committee report tabled for plenary, single reading
    • A8-0106/2015 summary
  • 2015/03/23 Vote in committee, 1st reading/single reading
  • 2014/10/20 Committee referral announced in Parliament, 1st reading/single reading
  • 2014/07/30 Non-legislative basic document published
    • COM(2014)0510 summary
    • DG {'url': 'http://ec.europa.eu/dgs/budget/', 'title': 'Budget'}, GEORGIEVA Kristalina

Documents

AmendmentsDossier
13 2014/2133(DEC)
2015/03/05 CONT 13 amendments...
source: 549.353

History

(these mark the time of scraping, not the official date of the change)

activities/4/type
Old
Debate in plenary scheduled
New
Debate scheduled
activities/1/committees/0/shadows/1/group
Old
NI
New
S&D
activities/1/committees/0/shadows/1/mepref
Old
53b2d70eb819f205b0000008
New
4f1ac627b819f25efd000021
activities/1/committees/0/shadows/1/name
Old
ALIOT Louis
New
BALČYTIS Zigmantas
activities/1/committees/0/shadows/2
group
ALDE
name
DLABAJOVÁ Martina
activities/1/committees/0/shadows/3
group
Verts/ALE
name
ŠOLTES Igor
activities/2/committees/0/shadows/1/group
Old
NI
New
S&D
activities/2/committees/0/shadows/1/mepref
Old
53b2d70eb819f205b0000008
New
4f1ac627b819f25efd000021
activities/2/committees/0/shadows/1/name
Old
ALIOT Louis
New
BALČYTIS Zigmantas
activities/2/committees/0/shadows/2
group
ALDE
name
DLABAJOVÁ Martina
activities/2/committees/0/shadows/3
group
Verts/ALE
name
ŠOLTES Igor
committees/0/shadows/1/group
Old
NI
New
S&D
committees/0/shadows/1/mepref
Old
53b2d70eb819f205b0000008
New
4f1ac627b819f25efd000021
committees/0/shadows/1/name
Old
ALIOT Louis
New
BALČYTIS Zigmantas
committees/0/shadows/2
group
ALDE
name
DLABAJOVÁ Martina
committees/0/shadows/3
group
Verts/ALE
name
ŠOLTES Igor
activities/3/docs/0/text
  • The Committee on Budgetary Control adopted the report by Ryszard CZARNECKI (ECR, PL) on discharge in respect of the implementation of the budget of the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines (IMI) for the financial year 2013.

    It called on the European Parliament to postpone its decision on granting the Executive Director of IMI 2 discharge in respect of the implementation of the budget of the Joint Undertaking for the implementation of the IMI for the financial year 2013.

    Members postponed the closure of the accounts of the Joint Undertaking for the financial year 2013. At the same time, they made a number of recommendations that needed to be taken into account when the discharge is granted, in addition to the general recommendations that appear in the draft resolution on performance, financial management and control of EU agencies.

    • Budgetary and financial management: Members noted that the error rate resulting from audits was at 5.82%, which meant that a qualified opinion was issued on the legality and the regularity of the transactions underlying the accounts of the Joint Undertaking, in view of the fact that the rate was above the materiality threshold of 2%.  Whilst acknowledging that follow-up actions related to audited beneficiaries with detected errors were launched, Members asked for an action plan with clear objectives aimed at fixing the deficiencies and errors identified by the Court to be submitted to the discharge authority in a timely manner. Members also asked IMI 2 to provide the discharge authority with detailed information on the in-kind contributions of EFPIA companies especially on the type of the in-kind contributions and their respective value. They also called on the Joint Undertaking to submit a report to the discharge authority concerning the contributions of all members other than the Commission including the application of the methodology for evaluating in-kind contributions, together with an assessment by the Commission.
    • Internal control: the committee observed that the Commission's Internal Audit Service (IAS) performed an assurance engagement of project management and reporting on operational performance, and included recommendations regarding improvements particularly regarding risk assessment of the Joint Undertaking's specific IT systems as well as the common infrastructure it shares with the FCH, Clean Sky, ENIAC and ARTEMIS Joint Undertakings.

    Members went on to make a series of observation on conflicts of interests at the Joint Undertaking as well as on the management of calls for proposals and the legal framework of IMI 2.

    Other observations: lastly, the committee called on IMI 2 to submit a report to the discharge authority on the social-economic benefits of the already completed projects and for that report to be submitted to the discharge authority together with an assessment by the Commission. It recalled that the discharge authority had previously requested the Court to draw up a special report on the capacity of the joint undertakings, together with their private partners, to ensure added value and efficient execution of Union research, technological development and demonstration programmes.

activities/5
date
2015-04-29T00:00:00
body
EP
type
Vote in plenary scheduled
activities/4/type
Old
Indicative plenary sitting date, 1st reading/single reading
New
Debate in plenary scheduled
activities/3/docs
  • url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2015-0106&language=EN type: Committee report tabled for plenary, single reading title: A8-0106/2015
activities/3
date
2015-03-31T00:00:00
body
EP
type
Committee report tabled for plenary, single reading
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament 1st reading / single reading / budget 1st stage
activities/2
date
2015-03-23T00:00:00
body
EP
type
Vote in committee, 1st reading/single reading
committees
activities/2
date
2015-03-23T00:00:00
body
EP
type
Vote scheduled in committee, 1st reading/single reading
activities/2/date
Old
2015-03-24T00:00:00
New
2015-03-23T00:00:00
activities/0/commission/0
DG
Commissioner
GEORGIEVA Kristalina
other/0
body
EC
dg
commissioner
GEORGIEVA Kristalina
activities/0/docs/0/text
  • PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2013, as part of the 2013 discharge procedure.

    Analysis of the accounts of the Joint Technology Initiative on Innovative Medicines (IMI).

    CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2013 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 129 (2) of the Financial Regulation applicable to the EU's General Budget, including the IMI Joint Undertaking.

    The document contains the figures on which the discharge procedure is based.

    Discharge procedure of the EU Joint Undertakings: the EU Budget finances a wide range of policies and programmes throughout the EU. In accordance with the priorities set by the European Parliament and the Council in the multi-annual financial framework (MFF), the European Commission carries out specific programmes, activities and projects in the field with the technical support of some specialised agencies.

    The consolidated annual accounts of the EU provide information on the activities of the institutions, agencies and other bodies of the EU from a budgetary and accrual accounting perspective.

    The consolidated reports on the implementation of the general budget of the EU include the budget implementation of all Institutions. Agencies and Joint Undertakings (JUs) do not have a separate budget inside the EU budget; and they are partially financed by a Commission budget subsidy.

    Each JU is subject to its own discharge procedure.

    IMI: in 2013, the tasks and budget of the Joint Undertaking were as follows:

    • description of the tasks of the Joint Undertaking: the IMI Joint undertaking, which is located in Brussels, was set up in 2007 by Council Regulation (EC) No 73/2008 for a period of 10 years. The IMI Joint Undertaking supports pre-competitive pharmaceutical research and development in the Member States and associated countries, aiming at increasing the research investment in the biopharmaceutical sector and promotes the involvement of small and medium-sized enterprises (SME) in its activities;
    • accounts of the JU: the maximum indicative contribution of the Commission to cover running costs and research activities is EUR 1 billion up to 31.12.2017. The cumulative unrecognised share of losses is EUR 16 million.

    Please also consult the final accounts of IMI Joint Undertaking.

activities/1/committees/0/shadows/1
group
EFD
name
VALLI Marco
committees/0/shadows/1
group
EFD
name
VALLI Marco
activities
  • date: 2014-07-30T00:00:00 docs: url: http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2014/0510/COM_COM(2014)0510_FR.pdf celexid: CELEX:52014DC0510:EN type: Non-legislative basic document published title: COM(2014)0510 body: EC type: Non-legislative basic document published commission:
  • date: 2014-10-20T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP shadows: group: EPP name: MARINESCU Marian-Jean group: NI name: ALIOT Louis responsible: True committee: CONT date: 2014-09-26T00:00:00 committee_full: Budgetary Control rapporteur: group: ECR name: CZARNECKI Ryszard body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: False committee_full: Industry, Research and Energy committee: ITRE
  • date: 2015-03-24T00:00:00 body: EP type: Vote scheduled in committee, 1st reading/single reading
  • date: 2015-04-28T00:00:00 body: EP type: Indicative plenary sitting date, 1st reading/single reading
committees
  • body: EP shadows: group: EPP name: MARINESCU Marian-Jean group: NI name: ALIOT Louis responsible: True committee: CONT date: 2014-09-26T00:00:00 committee_full: Budgetary Control rapporteur: group: ECR name: CZARNECKI Ryszard
  • body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI
  • body: EP responsible: False committee_full: Industry, Research and Energy committee: ITRE
links
other
    procedure
    dossier_of_the_committee
    CONT/8/01601
    reference
    2014/2133(DEC)
    title
    2013 discharge: IMI Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines
    stage_reached
    Awaiting committee decision
    type
    DEC - Discharge procedure
    subject
    8.70.03.03 2013 discharge